Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer
Clinical trial NCT06835400 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06835400
- Sponsor
- Health Hope Pharma
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-04-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.